https://exozymes.com/blog/nrel-doe-working-with-invizyne-in-their-advancing-clean-tech-to-energize-the-future-project-a-fireside-chathttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NREL.jpegNRELNRELhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/invizyne-technologies-announces-filing-of-registration-statement-for-proposed-offering-and-listing-on-nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/partnershttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/grow-your-biz.jpggrowyourbusinesswithexozymesgrowyourbizhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/blog/potential-impacthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-04%20at%2022.40.09%20(2)-1.pngScreenshot20250204at22400921Screenshot20250204at22400921https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-17https://exozymes.com/blog/gen-edge-whats-in-a-name-out-with-invizyne-in-with-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/What%E2%80%99s%20in%20a%20Name.pngWhatsinaNameWhatsinaNamehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-17https://exozymes.com/blog/bioclickhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/BioClick.jpgBioClickBioClick2025-04-10https://exozymes.com/blog/founder-storyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/tn_founding-eXoZ.pngtnfoundingeXoZtnfoundingeXoZ2026-02-02https://exozymes.com/blog/4q-full-year-2025-callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at1311592026-04-01https://exozymes.com/blog/invizyne-technologies-announces-name-change-to-exozymes-inc.-and-new-ticker-symbolhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/post_image.jpgpostimagepostimagehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-17https://exozymes.com/blog/4q-2025-investorcallhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-29%20at%2019.10.02.pngScreenshot20260329at191002Screenshot20260329at1910022026-04-01https://exozymes.com/blog/invizynes-nasdaq-ipo-marks-new-era-of-biomanufacturinghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Heltzen_IPO%2Bnasdaq.pngHeltzenIPOnasdaqHeltzenIPOnasdaq2026-02-02https://exozymes.com/blog/invizyne-technologies-selected-for-2-million-project-to-advance-sustainable-aviation-fuel-capabilitieshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/BioMADE%2BInvizyne.pngBioMADEInvizyneBioMADEInvizyne2026-02-02https://exozymes.com/blog/enzyme-break-outhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ChemEng.jpgChemEngChemEnghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-04-01https://exozymes.com/blog/slack-capital-ceohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ExoZymes%20-%20Introduction%20(1).pngExoZymesIntroduction1ExoZymesIntroduction1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-05-22https://exozymes.com/sec-filingshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/blog/invizyne-technologies-to-begin-trading-on-nasdaq-on-november-13-2024https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/nasdaq-closing-bell-ceremonyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/mc_021925_highres11.jpgmc021925highres11mc021925highres11https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-23https://exozymes.com/blog/2025-ibt-exozhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/IBT.jpgIBTIBT2025-12-17https://exozymes.com/blog/upside-interview-episode2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Upside-thumbnail.pngUpsidethumbnailUpsidethumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/blog/slack-capital-chairmanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ExoZymes%20-%20MDB%20Capital%20(1).pngExoZymesMDBCapital1ExoZymesMDBCapital1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-05-22https://exozymes.com/blog/refreshed-brand-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_logo(powered).pngEXOZlogopoweredEXOZlogopowered2026-02-10https://exozymes.com/blog/invizyne-technologies-announces-closing-of-initial-public-offeringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosq2026-02-02https://exozymes.com/blog/q2-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ%20Q2%20earnings%20call.pngeXoZQ2earningscalleXoZQ2earningscall2026-02-09https://exozymes.com/blog/michael-burns-joins-invizyne-as-executive-vice-president-of-energy-transitionhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/fuelpump.jpgfuelpumpfuelpumphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/a-bio-inspired-cell-free-system-for-cannabinoid-production-from-inexpensive-inputshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2020_naturechembio.jpeg2020naturechembio2020naturechembio2026-02-02https://exozymes.com/blog/new-ccohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien-(square-thumbnail).jpgDamiensquarethumbnailDamiensquarethumbnail2026-04-02https://exozymes.com/blog/tyleramy2025-11-13https://exozymes.com/blog/invizyne-ipo-interview-with-dr.-james-j.-lalonde-by-mdb-capital-president-and-chief-market-strategist-lou-basenesehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_lalonde.jpgexolalondeexolalonde2026-02-02https://exozymes.com/blog/vanity-fair-ncthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Vanity_Fair.jpgVanityFairVanityFairhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-11-26https://exozymes.com/blog/a-cell-free-platform-for-the-prenylation-of-natural-products-and-application-to-cannabinoid-productionhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-27%20at%2016.20.06.pngScreenshot20250227at162006Screenshot20250227at1620062026-02-02https://exozymes.com/blog/world-bio-market-insights-perrimanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/WBMI-Retina.webpWBMIRetinaWBMIRetina2025-04-07https://exozymes.com/blog/nasdaq-interview-heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail-11.gifthumbnail11thumbnail11https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/blog/mdb-capital-ceo-and-invizyne-board-member-chris-marlett-presents-the-invizyne-story-and-initial-public-offering-ipo-opportunity-to-investors-via-zoom-on-june-11-2024https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_chris.jpgexochrisexochrishttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/mdb-capital-announces-record-date-and-expected-timing-for-initial-public-offering-for-invizyne-technologieshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/2025-beryl-elites-ai-panelhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Panel_Michael.jpgPanelMichaelPanelMichael2025-12-15https://exozymes.com/blog/invizyne-technologies-begins-trading-on-nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/bloghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NLR.jpgNLRNLRhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-12%20at%2023.00.10.pngScreenshot20260312at230010Screenshot20260312at230010https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogobusinessinsiderlogobusinessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-29%20at%2019.10.02.pngScreenshot20260329at191002Screenshot20260329at191002https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-01%20at%2013.50.47.pngScreenshot20260401at135047Screenshot20260401at135047https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogousatodaylogousatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(SoMe).jpgthumbnailSoMethumbnailSoMehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnailinvestorthumbnailinvestorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at1311592026-02-06https://exozymes.com/blog/transcript-q4-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-01%20at%2013.50.47.pngScreenshot20260401at135047Screenshot20260401at1350472026-04-01https://exozymes.com/blog/ceo-michael-heltzen-and-co-founder-vp-of-research-dr.-tyler-korman-present-the-invizyne-story-and-ipo-opportunity-to-investorshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Michael%2BTyler.jpgCEOMichaelHeltzenleftandTylerKormanPhDcofounderandVPofResearchrightMichaelTylerhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/usa-today-caymanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogousatodaylogousatoday2026-03-23https://exozymes.com/blog/slack-capital-vpofresearchhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/ExoZymes%20-%20Science%20(1).pngExoZymesScience1ExoZymesScience12025-05-22https://exozymes.com/hiddenstockhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-05https://exozymes.com/technologyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail.pngthumbnailthumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/grow-your-biz(banner).jpggrowyourbusinesswithexozymesgrowyourbizbannerhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCT-for-testing(edit).jpgNCTfortestingeditNCTfortestingedithttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCTx_logo.pngNCTxlogoNCTxlogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/business-model-4.svgbusinessmodel4businessmodel4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul2.jpgPaul2Paul2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien%2BNCT(thumbnail).jpgDamienNCTthumbnailDamienNCTthumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul%2BNCT(HD).jpgPaulNCTHDPaulNCTHDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/BiochemistryWorkflow(eXoZ)-3.pngBiochemistryWorkfloweXoZ3BiochemistryWorkfloweXoZ3https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_Perriman%2BOpgenorth.jpgEXOZPerrimanOpgenorthEXOZPerrimanOpgenorth2026-02-20https://exozymes.com/blog/a-synthetic-biochemistry-platform-for-cell-free-production-of-monoterpenes-from-glucosehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-27%20at%2016.20.06.pngScreenshot20250227at162006Screenshot20250227at162006https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/transcript-q2-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/sc_team%2Bcall.pngscteamcallscteamcallhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-08-13https://exozymes.com/exozhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at131159https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ-logo(SoMe).pngeXoZlogoSoMeeXoZlogoSoMehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnailinvestorthumbnailinvestorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogobusinessinsiderlogobusinessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogousatodaylogousatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGEN2026-02-06https://exozymes.com/blog/gen-biotech-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GENbio_thumbnail(HD).pngGENbiothumbnailHDGENbiothumbnailHD2025-04-21https://exozymes.com/blog/transcript-1st-quarter-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Q1-earnings-call%2BNCTx-1.pngQ1earningscallNCTx1Q1earningscallNCTx1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-05-14https://exozymes.com/blog/challenges-of-synbiohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-09-15%20at%2017.42.51%20(2).pngScreenshot20250915at1742512Screenshot20250915at1742512https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-09-15https://exozymes.com/blog/beryl-elites-interview-heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-01-07%20at%2016.21.06.pngScreenshot20260107at162106Screenshot20260107at1621062026-01-07https://exozymes.com/blog/2025thinkequityconfhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-10-23%20at%2022.28.58.pngScreenshot20251023at222858Screenshot20251023at222858https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-10-23https://exozymes.com/blog/invizyne-technologies-expands-leadership-team-ahead-of-proposed-offering-and-listing-on-nasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Heltzen_IPO%2Bnasdaq.pngHeltzenIPOnasdaqHeltzenIPOnasdaq2026-02-02https://exozymes.com/blog/difference-between-enzymes-and-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-07%20at%2014.51.08%20(2).pngScreenshot20250207at1451082Screenshot20250207at1451082https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-17https://exozymes.com/blog/grow-everything-podcasthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail.jpgthumbnailthumbnail2025-10-02https://exozymes.com/blog/firesidechat-part4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-01-13%20at%2023.31.19%20(2).pngScreenshot20250113at2331192Screenshot20250113at23311922026-02-17https://exozymes.com/blog/creating-value-for-partnershttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-05%20at%2019.47.16%20(2).pngScreenshot20250205at1947162Screenshot20250205at1947162https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-17https://exozymes.com/blog/podcast-the-catalyst-interviewhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Podcast%20Thumbnail_%20Michael%20Heltzen.pngPodcastThumbnailMichaelHeltzenPodcastThumbnailMichaelHeltzen2025-10-17https://exozymes.com/blog/perriman-nasdaq-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien@Nasdaq(SoMe).jpgDamienNasdaqSoMeDamienNasdaqSoMe2026-04-02https://exozymes.com/blog/invizyne-selected-by-shell-gamechanger-accelerator-powered-by-nrel-for-sixth-cohorthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/nct-otchttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/peppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HD.mp4/medium.jpgpeppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HDpeppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/peppercorns-or-black-pepper-spice-super-macro-close-up-black-pepper-is-a-flowering--SBV-349378509-HD.mp46nonohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/HNF4%CE%B1.pngHNF4αHNF4αhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/naturalproducts.svgnaturalproductsnaturalproducts2026-02-18https://exozymes.com/blog/q1-2025nctxhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Q1-earnings-call%2BNCTx.pngQ1earningscallNCTxQ1earningscallNCTx2025-05-07https://exozymes.comhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Nasdaq.svglogoNasdaqlogoNasdaqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at131159https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_FoxBiz.svglogoFoxBizlogoFoxBizhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_IBT.svglogoIBTlogoIBThttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogobusinessinsiderlogobusinessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_LAweekly.svglogoLAweeklylogoLAweeklyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_ChemEng.svglogoChemEnglogoChemEnghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCT-for-testing(edit).jpgNCTfortestingeditNCTfortestingedithttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_FastCo.svglogoFastCologoFastCohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_Bloomberg.svglogoBloomberglogoBloomberghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_GEN.svglogoGENlogoGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_WorldBioMarket.svglogoWorldBioMarketlogoWorldBioMarkethttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-TEAM.jpgEXOZTEAMEXOZTEAMhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_logo(powered).pngEXOZlogopoweredEXOZlogopoweredhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogousatodaylogousatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_VanityFair.svglogoVanityFairlogoVanityFairhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_yahoo.svglogoyahoologoyahoo2026-03-23https://exozymes.com/blog/nct-breakthrough-purityhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Damien%2BNCT(thumbnail).jpgDamienNCTthumbnailDamienNCTthumbnailhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-07-29https://exozymes.com/blog/fox-business-heltzenhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-13%20at%2021.45.28.pngScreenshot20250313at214528Screenshot20250313at2145282026-03-04https://exozymes.com/blog/bio-innovations-midwest-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/54806567196_1c63f9d30b_k.jpg548065671961c63f9d30bk548065671961c63f9d30bk2025-10-08https://exozymes.com/blog/100x-scale-uphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_100xScaleUp.jpgEXOZ100xScaleUpEXOZ100xScaleUphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-12-11https://exozymes.com/blog/nctx-launchhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCTx_logo.pngNCTxlogoNCTxlogo2026-02-09https://exozymes.com/blog/transcript-exoz-q3-2025-update2025-11-14https://exozymes.com/abouthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8772-edited.jpg25A8772edited25A8772editedhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8526.jpg25A852625A8526https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at131159https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8809.jpg25A880925A8809https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8604.jpg25A860425A8604https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8726-edited.jpg25A8726edited25A8726editedhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnailinvestorthumbnailinvestorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A9143.jpg25A914325A9143https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-12%20at%2023.00.10.pngScreenshot20260312at230010Screenshot20260312at230010https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8660.jpg25A866025A8660https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(SoMe).jpgthumbnailSoMethumbnailSoMehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogobusinessinsiderlogobusinessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8547.jpg25A854725A8547https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8569%20(1).jpg25A8569125A85691https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8641.jpg25A864125A8641https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogousatodaylogousatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/James.jpgJamesJameshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8517.jpg25A851725A8517https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8620-edited2.jpg25A8620edited225A8620edited2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ-TEAM.jpgEXOZTEAMEXOZTEAMhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/25_A8557.jpg25A855725A85572026-02-09https://exozymes.com/partner-to-behttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/jobshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-03-04https://exozymes.com/blog/a-molecular-rheostat-maintains-atp-levels-to-drive-a-synthetic-biochemistry-systemhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2017_naturechembio.jpeg2017naturechembio2017naturechembiohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/cayman-validationhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(SoMe).jpgthumbnailSoMethumbnailSoMehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-03-18https://exozymes.com/blog/meta-pure-granthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul2.jpgPaul2Paul2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-06-26https://exozymes.com/nct-pharmahttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/glp1.svgglp1glp1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/MasterMetabolicSwitch.pngMasterMetabolicSwitchMasterMetabolicSwitch2026-02-06https://exozymes.com/blog/firesidechat-part3https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-01-13%20at%2023.31.07%20(2).pngScreenshot20250113at2331072Screenshot20250113at23310722026-02-02https://exozymes.com/blog/jane-king-interviews-ceo2025-11-12https://exozymes.com/blog/transcript-4th-quarter-and-full-year-2024-from-april-2-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-04-03%20at%2015.20.33.pngScreenshot20250403at152033Screenshot20250403at1520332025-04-29https://exozymes.com/blog/cso2025-11-13https://exozymes.com/sec-filings-2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ-logo-red.svgeXoZlogoredeXoZlogoredhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/bg_dt-bridge(dark).jpgbgdtbridgedarkbgdtbridgedarkhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/bg_charcoal%2Btiffany.jpgbgcharcoaltiffanybgcharcoaltiffanyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/hiring.jpghiringhiringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail-11.gifthumbnail11thumbnail11https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/website-gfx/hex_X.svghexXhexXhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/website-gfx/bg_dt-bridge.pngbgdtbridgebgdtbridge2025-02-12https://exozymes.com/blog/bloomberg-kormanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-04-15%20at%2015.19.05.pngScreenshot20250415at151905Screenshot20250415at151905https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-04-29https://exozymes.com/blog/2025-mdb-capital-summithttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-12-21%20at%2023.59.16.pngScreenshot20251221at235916Screenshot20251221at235916https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-12-21https://exozymes.com/blog/business-insider-caymanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogobusinessinsiderlogobusinessinsider2026-03-23https://exozymes.com/blog/2025berylelitesconfhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/1761745128907.jpeg17617451289071761745128907https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-10-30https://exozymes.com/blog/2025-q2-callhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ%20Q2%20earnings%20call.pngeXoZQ2earningscalleXoZQ2earningscall2025-08-07https://exozymes.com/signuphttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at131159https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_businessinsider.svglogobusinessinsiderlogobusinessinsiderhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnailinvestorthumbnailinvestorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_usatoday.svglogousatodaylogousatodayhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/fcoihttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-07https://exozymes.com/blog/confcall2024https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-26%20at%2016.01.20%20(2).pngScreenshot20250326at1601202Screenshot20250326at1601202https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-04-01https://exozymes.com/blog/nct-breakthrough-paulhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul%2BNCT(HD).jpgPaulNCTHDPaulNCTHDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-07-22https://exozymes.com/investorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-02-26%20at%2023.26.23.pngScreenshot20260226at232623Screenshot20260226at232623https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-04-01%20at%2013.50.47.pngScreenshot20260401at135047Screenshot20260401at135047https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/James%20Bowie.jpgJamesBowieJamesBowiehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-25%20at%2013.11.59.pngScreenshot20260325at131159Screenshot20260325at131159https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Anthony%20DiGiandomenico.webpAnthonyDiGiandomenicoAnthonyDiGiandomenicohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-29%20at%2019.10.02.pngScreenshot20260329at191002Screenshot20260329at191002https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Jim%20Lalonde%2c%20Ph.D..webpJimLalondePhDJimLalondePhDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_edgardo.jpgexoedgardoexoedgardohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-31%20at%2013.27.55.pngScreenshot20260331at132755Screenshot20260331at132755https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-10-06%20at%2013.47.04%20(2).pngScreenshot20251006at1347042Screenshot20251006at1347042https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Committee%20Composition%20(2700%20x%20675%20px).pngCommitteeComposition2700x675pxCommitteeComposition2700x675pxhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_lonbell.jpgexolonbellexolonbellhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-31%20at%2013.30.30.pngScreenshot20260331at133030Screenshot20260331at133030https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_chris.jpgexochrisexochrishttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnailinvestorthumbnailinvestorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/business-model-4.svgbusinessmodel4businessmodel4https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-04-02https://exozymes.com/blog/a-synthetic-biochemistry-system-for-the-in-vitro-production-of-isoprene-from-glycolysis-intermediateshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2014_proteinscience.jpg2014proteinscience2014proteinscience2026-02-02https://exozymes.com/blog/2025-podcast-lightning-rxhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-12-17%20at%2014.32.50.pngScreenshot20251217at143250Screenshot20251217at1432502025-12-17https://exozymes.com/blog/2025-fast-companyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/20251121_FastCompany.jpg20251121FastCompany20251121FastCompanyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-12-16https://exozymes.com/blog/firesidechat-part2https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202024-12-31%20at%2001.05.49%20(2).pngScreenshot20241231at0105492Screenshot20241231at0105492https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/2025-3q-updatehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-11-13%20at%2012.35.54.pngScreenshot20251113at123554Screenshot20251113at123554https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-09https://exozymes.com/blog/nct-pilot-run-detailshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NCT-for-testing(edit).jpgNCTfortestingeditNCTfortestingedithttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-01-30https://exozymes.com/blog/exoz-ai-part12025-11-11https://exozymes.com/blog/wbm25-panelhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-07-01%20at%2023.46.17.pngScreenshot20250701at234617Screenshot20250701at234617https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-10-08https://exozymes.com/blog/announce-2025-3qt-earnings-call2025-11-10https://exozymes.com/blog/2024-10khttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-26%20at%2016.01.20%20(2).pngScreenshot20250326at1601202Screenshot20250326at16012022026-04-02https://exozymes.com/blog/invizyne-technologies-announces-pricing-of-15-million-initial-public-offeringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosq2026-02-02https://exozymes.com/blog/gen-biotechnology-coverstory2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GENBIO-cover.pngGENBIOcoverGENBIOcover2025-06-26https://exozymes.com/blog/la-weekly-jbhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/LA_Weekly_logo.jpgLAWeeklylogoLAWeeklylogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-11-26https://exozymes.com/blog/with-nrels-help-gcxn-company-readies-for-initial-public-offeringhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-10%20at%2000.15.01.pngScreenshot20250210at001501Screenshot20250210at001501https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/alphafold-to-exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Paul%2BAI.pngPaulAIPaulAIhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-04-28https://exozymes.com/blog/synthetic-biochemistry-the-bio-inspired-cell-free-approach-to-commodity-chemical-productionhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2020_cell.jpg2020cell2020cell2026-02-02https://exozymes.com/blog/biomade-thought-leadershttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/EXOZ_Perriman%2BOpgenorth.jpgEXOZPerrimanOpgenorthEXOZPerrimanOpgenorth2025-09-30https://exozymes.com/blog/once-in-a-lifetime-opportunity2025-11-19https://exozymes.com/blog/exozymes-pitchhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Heltzen%2Bequation.jpgenzymesxAIexozymesHeltzenequation2026-02-17https://exozymes.com/blog/commercializing-invizynes-cell-free-platform-fireside-chat-with-zachary-karl-phd-vp-of-bizdev-and-lou-basenese-president-chief-market-strategist-at-mdb-capitalhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_zach.jpgZacharyKarlPhDVPofBusinessDevelopmentexozachhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/firesidechat-part1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202024-12-30%20at%2023.38.58%20(2).pngScreenshot20241230at2338582Screenshot20241230at23385822026-02-02https://exozymes.com/blog/2026-mista-perrimanhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-03-12%20at%2023.00.10.pngScreenshot20260312at230010Screenshot20260312at230010https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-03-12https://exozymes.com/blog/ceo-buys-iztc-stockhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/invizyne-logo(sq).pngInvizyneTechnologiesIncinvizynelogosqhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/santalenehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/santalene.svgsantalenesantalenehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-06https://exozymes.com/blog/invizyne-awarded-additional-3.77-million-grant-from-u.s.-department-of-energyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2025-02-09https://exozymes.com/pipelinehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/naturalproducts.svgnaturalproductsnaturalproductshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/pharmaceuticals.svgpharmaceuticalspharmaceuticalshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-02-06%20at%2014.33.52.pngScreenshot20260206at143352Screenshot20260206at143352https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/business-model-4.svgbusinessmodel4businessmodel42026-02-20https://exozymes.com/blog/q1-2025https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Q1-earnings-call%2BNCTx-1.pngQ1earningscallNCTx1Q1earningscallNCTx1https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-09https://exozymes.com/terms-of-usehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-07https://exozymes.com/blog/a-synthetic-biochemistry-module-for-production-of-bio-based-chemicals-from-glucosehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/2016_naturechembio.png2016naturechembio2016naturechembio2026-02-02https://exozymes.com/blog/leadership-transition-rayohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/exo_edgardo.jpgexoedgardoexoedgardo2026-02-23https://exozymes.com/blog/a-synthetic-biochemistry-molecular-purge-valve-module-that-maintains-redox-balancehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-02-27%20at%2016.20.06.pngScreenshot20250227at162006Screenshot20250227at162006https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-02https://exozymes.com/blog/nasdaq-bell-ringinghttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Nasdaq.jpgNasdaqNasdaq2026-02-23https://exozymes.com/blog/big-skinny-basf-of-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-02-26%20at%2023.26.23.pngScreenshot20260226at232623Screenshot20260226at2326232026-02-27https://exozymes.com/blog/inside-biotech-podcasthttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Square_Michael%20Heltzen.pngSquareMichaelHeltzenSquareMichaelHeltzen2025-10-02https://exozymes.com/blog/yahoo-finance-2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/logo_yahoo.svglogoyahoologoyahoohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-20https://exozymes.com/blog/slack-capital-ccohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/_ExoZymes%20-%20Commercial%20(1).pngExoZymesCommercial1ExoZymesCommercial12025-05-20https://exozymes.com/blog/beryl-elites-interview-sanjeevhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202026-01-07%20at%2016.47.30.pngScreenshot20260107at164730Screenshot20260107at1647302026-01-08https://exozymes.com/blog/fox-business-basenesehttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-03-17%20at%2015.57.12.pngScreenshot20250317at155712Screenshot20250317at155712https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-04-01https://exozymes.com/blog/2025-spartan-capital-confhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/Screenshot%202025-10-29%20at%2022.14.43.pngScreenshot20251029at221443Screenshot20251029at2214432025-10-29https://exozymes.com/blog/nlr-why-use-living-cellshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/NLR.jpgNLRNLR2026-03-27https://exozymes.com/privacy-policyhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-02-07https://exozymes.com/blog/gen-march2026https://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/GEN.jpgGENGENhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-03-23https://exozymes.com/cannabinoidshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/slow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HD.mp4/medium.jpgslow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HDslow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HDhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/slow-motion-close-up-of-biological-and-ecological-hemp-plants-in-a-greenhouse-shot--SBV-348974380-HD.mp414nonohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/pharmaceuticals-1.svgpharmaceuticals1pharmaceuticals12026-02-06https://exozymes.com/blog/exozymeshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogohttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZ-logo(SoMe)-1.pngeXoZlogoSoMe1eXoZlogoSoMe12026-02-17https://exozymes.com/blog/cayman-validation-investorshttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/thumbnail(investor).jpgthumbnailinvestorthumbnailinvestorhttps://48235418.fs1.hubspotusercontent-na2.net/hubfs/48235418/eXoZymes-logo.svgeXoZymeslogoeXoZymeslogo2026-03-18